Adis JournalsBrowse
Summary Slide.png (118.93 kB)
Download file

Oral Semaglutide Reduces HbA1c and Body Weight in Patients With Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses

Download (118.93 kB)
figure
posted on 2021-01-18, 11:24 authored by Adis journals on behalf of, Richard E. Pratley, Matthew J. Crowley, Mette Gislum, Christin L. Hertz, Thomas B. Jensen, Kamlesh Khunti, Ofri Mosenzon, John B. Buse

Article full text


The above summary slide and graphical abstract represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.


History

References

Usage metrics

Read the peer-reviewed publication

Oral Semaglutide Reduces HbA1c and Body Weight in Patients With Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses
Diabetes TherapyDiabetes Therapy

Categories

Keywords

Diabetes mellitus, type 2Glucagon-like peptidesHypoglycaemic agentsInsulinMetforminOral semaglutideSodium-glucose cotransporter 2 inhibitorsSulphonylurea compounds

Licence

CC BY-NC 4.0

Exports